tm logo
APONVIE
SEARCHED

on 07 Aug 2024

Last Applicant/ Owned by

HERON THERAPEUTICS INC.

4242 Campus Point Court, Suite 200San Diego CA 92121

US

Serial Number

2257288 filed on 30th Mar 2023

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

APONVIE

Vienna Information


26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 7 . 4

Circles or ellipses with lines (except 26.7.3)Cercles ou ellipses avec lignes (excepté 26.7.3)

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

Trademark usage description

anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the ma Read More

Classification Information


Class [005]
Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy


Classification kind code

12

Class [042]
Providing scientific and medical research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development services; product research and development services


Classification kind code

12

Class [044]
Providing medical and other health and wellness information to medical professionals in the fields of oncology and pain management; providing medical information; providing medical information via a website.


Classification kind code

12

Mark Details


Serial Number

2257288

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 29th Aug 2024
Agent Changed
Submitted for opposition 22
on 07th Aug 2024
Search Recorded
Submitted for opposition 20
on 07th Aug 2024
Examiner's First Report
Submitted for opposition 223
on 07th Aug 2024
Total Provisional Refusal
Submitted for opposition 256
on 11th Mar 2024
Notification of Possible Opposition Sent
Submitted for opposition 257
on 11th May 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 10th May 2023
Created
Submitted for opposition 31
on 10th May 2023
Formalized
Submitted for opposition 228
on 30th Mar 2023
International Registration
Submitted for opposition 30
on 30th Mar 2023
Filed